TPG Capital acquires Adare Pharmaceuticals, Inc.

On April 2, 2015, TPG Capital acquired Adare Pharmaceuticals, Inc., a life science company in New Jersey, United States, from Allergan plc.

Deal at a glance

AnnouncedApril 2, 2015 TypeDivestiture TargetAdare Pharmaceuticals, Inc. Buyer TPG Capital Seller Allergan plc SectorLife Science LocationNew Jersey, United States ValueNot disclosed

Target company

Adare Pharmaceuticals, Inc.

New Jersey, United States

Life Sciencesector

1968founded

Activestatus

View the company profile →

Buyer

TPG Capital

Private equity firm · 478 deals on record

30th transaction in life science
162nd transaction in United States

478deals, all time

44in this sector

2026latest

Seller

Allergan plc

Company · 10 deals on record

10investments

6in this sector

3exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Tablet Command, Inc.Same lead buyer · Sep 2026

LearfieldSame lead buyer · Apr 2026

Hologic, Inc.Same lead buyer · Apr 2026

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Adare Pharmaceuticals, Inc.?TPG Capital acquired Adare Pharmaceuticals, Inc. on April 2, 2015.

Who sold Adare Pharmaceuticals, Inc.?Allergan plc was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2015.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).